Compared with the two control groups, these rates were significantly higher (EPVL group was 0% and 50.5% and medical expulsive therapy group was 0% and 50.0%, p  0.05). In the EPVL plus tamsulosin group, 60.1% of patients showed detectable fragment expulsion at 48 hours, and 91.1% were stone free at 7 days. Stone diameters ranged from 0.32 to 1 cm. There were no significant differences in general characteristics between the three groups. Between July 2013 and July 2014, 672 patients diagnosed with DUC were randomly divided into three groups a group receiving EPVL plus 0.4 mg oral tamsulosin daily (PO qd) (experimental group, n = 236), a group receiving 0.4 mg tamsulosin PO qd (n = 222), and a group receiving EPVL only (n = 214) (control groups). The aim of this study was to evaluate a new technology, extracorporeal physical vibrational lithecbole (EPVL) combined with tamsulosin, as a treatment for distal ureteral calculi (DUC). The obstruction of the urinary tract by calculi at the narrowest anatomical areas leads to impaired drainage and severe pain. Liu, Guanlin Cheng, Yue Wu, Weijie Jia, Xiaolong Hu, Jiasheng Xie, Guohai Chen, Xueqin Treatment of Distal Ureteral Calculi Using Extracorporeal Physical Vibrational Lithecbole Combined with Tamsulosin: A New Option to Speed Up Obstruction Relief.
0 Comments
Leave a Reply. |